Alzheimer’s disease has disrupted and devastated families for decades. Researchers in Indiana and around the world have sought solutions to one of our most vexing medical conditions, and real progress is being made. Indiana’s role is significant and our hosts will set the stage for an important discussion.

• Melina Kennedy, CEO, Central Indiana Corporate Partnership
• Dan Peterson, Chairman, BioCrossroads
• Phyllis Ferrell, Global Head, Alzheimer’s External Engagement, Eli Lilly and Company

Alzheimer’s presents numerous challenges for people living with the disease and their families alike, including financial, physical, social, disease progression, and – historically – a lack of treatment options. Our panel will unveil the issues faced by families and underscore what progress would look like, including recent successes in Indiana and elsewhere.

Moderator:

• Phyllis Ferrell, Eli Lilly and Company

Panelists:

• Maria Carrillo, Chief Science Officer, the Alzheimer’s Association
• John Dwyer, President, Global Alzheimer’s Foundation
• Natalie Sutton, Chapter Executive, Alzheimer’s Association of Indiana

Breakthroughs are on the horizon. Biopharmaceutical companies, leading research universities, and newer biotech companies are driving scientific innovation that could make a difference for people everywhere. How are Indiana life sciences organizations driving meaningful change?

Keynote Remarks (10:35-11 AM)

• Bruce Lamb, M.D., Executive Director, Stark Neuroscience Research Institute, Indiana University School of Medicine

Panel Discussion: Near-Term Hope for the Community (11-11:45 AM)

Moderator:

Panelists:

• Bruce Lamb, M.D., Executive Director, Stark Neuroscience Research Institute, Indiana University School of Medicine
• Jared Brosch, Associate Professor, Indiana University School of Medicine
• Dawn Brooks, Global Business Development Leader, Alzheimer’s, Eli Lilly and Company

Panel Discussion: Longer-Term Hope for the Community (11:45 AM-12:30 PM)

Moderator:

Panelists:

• Alan Palkowitz, M.D., President and CEO, Indiana Biosciences Research Institute
• Derek Small, Managing Director, Luson Bioventures and Chairman/CEO of Monument Biosciences
• Cristian Lasagna-Reeves, Associate Professor at the Indiana University School of Medicine, Director of Neurodegenerative Disorders Research Group, Stark Neurosciences Research Institute
• Russ Barton, Chief Operating Officer, Acumen Pharmaceuticals

The diagnosis of Alzheimer’s disease is emotionally overwhelming, with unknown hurdles ahead for people whose families haven’t experienced it. People living with the disease, their caregivers, advocacy groups, and others who understand the personal and medical burdens, can articulate fear and how we can cope.

Part I: A conversation with someone living with Alzheimer’s

Moderator:

• Natalie Sutton, Chapter Executive, Alzheimer’s Association of Indiana, who will talk to Darlene Bradley, an Indiana resident who lives with Alzheimer’s.

Part II: A discussion around helping people and their families

Moderator:

• Natalie Sutton, Chapter Executive, Alzheimer’s Association of Indiana

Panelists:

• Karen Campbell, reporter, WTHR-Channel 13 and a caretaker for her mother who lives  with Alzheimer’s. 
• Dustin Ziegler, program director, Elevance Health 
• Tina McIntosh, founder, Joy’s House 

Moderator:

Panelists:

• Brandy Matthews, Vice President, Global and US Medical Affairs, Eli Lilly and Company 
• Laura Parnas, Neurosciences Lead, Roche Diagnostics 

• Tatiana Foroud, M.D., Executive associate dean for Research Affairs at the IU School of Medicine

• Dan Peterson, Chairman, BioCrossroads

• Dan Peterson, Chairman, BioCrossroads